MedTrace Logo

Effect of Propranolol on the Autonomic Nervous System and Muscle Pain

NCT01333150 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2012-03-26

No results posted yet for this study

Summary

The project's primary purpose is to test the hypothesis that oral administration of a low single dose of β-antagonist propranolol (40 mg) reduces pain sensitivity in patients with masticatory muscle pain.

Conditions

  • Temporomandibular Joint Disorders
  • Myofascial Temporomandibular Disorders

Interventions

DRUG

Propranololhydrochlorid

One single dose of Propranolol tablet of 40 mg randomized in one of the two sessions

DRUG

Placebo

One single dose of placebo

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Peter Svensson, DDS, PhD, Dr.Odont · University of Aarhus

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01333150 on ClinicalTrials.gov